Deals

A miner, shirtless and streaked with black dust, looks up toward the camera from inside a dark pit.

The Long View: The Engine Behind The Dealmaking

A cluster of recent deals put AI discovery platforms at the center. The terms, optioned and hedged, are more cautious than the conviction suggests.

Jun 19, 2026 Capsul Desk 5 min read members

Milestone Monday: What You'll Pay & Who You're Allowed to Pay It To

GSK spends $10.6bn to outrun a patent cliff while the Pentagon quietly reprices the supply chain underneath everyone. Two different bets on the same question: what is access actually worth.

Jun 15, 2026 Capsul Desk 10 min read members

A scientist in a white lab coat and blue gloves works at a lab bench, holding a pipette and looking down in concentration, with reagent bottles and supplies on the shelves beside him.

Therapeutic Thursday: The Crowd Is The Problem. Everyone Has A Different Solution.

Two of pharma's most crowded fields, and no agreement on whether the answer is to crowd in further or step away.

Jun 11, 2026 Aakash Babu 5 min read members

Milestone Monday: A $10.5 Billion China Bet And A Missing NDA

ASCO ended a week ago. The filing and the deal structure that deserve a closer look.

Jun 8, 2026 Capsul Desk 4 min read members

DND. Milestone Monday. The Noise Stops Here.

You are reading this before anyone outside this room does. That is not a formality. The people who build something should be the first to see it.

May 18, 2026 Aakash Babu 13 min read members

Page 1 of 1

The Long View: The Engine Behind The Dealmaking

Milestone Monday: What You'll Pay & Who You're Allowed to Pay It To

Therapeutic Thursday: The Crowd Is The Problem. Everyone Has A Different Solution.

Milestone Monday: A $10.5 Billion China Bet And A Missing NDA

DND. Milestone Monday. The Noise Stops Here.